FDA Inspection 1194208 — Innovative Blood Resources
The FDA completed an inspection of Innovative Blood Resources on December 14, 2022 in Lincoln, NE. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 14, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Lincoln, NE (United States)